Company Spotlight features video, webcasts, presentations and annual reports for more than 30,000 companies. Sign up to promote your company. ×
ReNeuron Group Plc
Pharmaceutical Preparations United Kingdom
London Stock Exchange: RENE
Company Description
ReNeuron Group Plc produces cell therapy products. It engages in the research, development, and commercial exploitation of stem cell technologies for therapeutic and non-therapeutic applications. The company's lead therapeutic candidate is ReN001 stem cell therapy for the treatment of patients left disabled by the effects of a stroke. It also develops ReN009 stem cell therapy for the treatment of peripheral arterial disease; and ReN003 stem cell therapy program for blindness-causing diseases of the retina, such as retinitis pigmentosa. The company develops and markets a range of stem cell lines, including ReNcell CX and ReNcell VM neural cell lines for use in academic and commercial research in non-therapeutic applications worldwide. ReNeuron Group was founded in 1997 by John David Sinden and is headquartered in Guildford, the United Kingdom.
Similar to: Sareum Holdings Plc, ViroPharma, Inc., AstraZeneca Plc
Featured Company
Utilico Emerging Markets Ltd.
Epsom, SU, GB
Utilico Emerging Markets Ltd. (UEM) is the UK-based global emerging markets investment arm of Computershare, Ltd. (SY: CPU) in Australia.… Learn more →
You may also be interested in:
AstraZeneca Plc
London, LO, GB
AstraZeneca Plc is a global research-based biopharmaceutical company, which discovers, develops and markets medicines for gastrointestinal,… Learn more →
ViroPharma, Inc.
Exton, PA, US
ViroPharma is rare among biotechnology companies. We are in the enviable position of having a strong and growing balance sheet; a… Learn more →
Sareum Holdings Plc
Cambridge, EA, GB
Sareum is a drug discovery company, headquartered in Cambridge UK, that produces targeted small molecule therapeutics, focusing on… Learn more →